01 / ATLAS

What it is

NAD+ is nicotinamide adenine dinucleotide, a coenzyme involved in metabolic reactions. It is not a peptide; it is included because it frequently appears in the same discussions about metabolism. [1]

02 / ATLAS

How it works

NAD+ participates in electron transfer and cellular processes that consume this coenzyme. Its biological role does not demonstrate that an infusion provides an additional clinical benefit. [1]

03 / ATLAS

What research shows

A pilot study tracked changes in NAD+ and its metabolites in blood and urine. It did not demonstrate rejuvenation, treatment of fatigue or lifespan extension. [1]

04 / ATLAS

Study data

Grant et al., 2019: 11 men, including 8 in the NAD+ group and 3 controls; short-term measurements after infusion. The small sample and metabolic focus limit therapeutic conclusions. [1]

05 / ATLAS

Safety and observed adverse reactions

No adverse events were observed in the small group during follow-up. This does not establish long-term safety or safety in other populations and products. [1]

06 / ATLAS

Research status

Early clinical data on intravenous administration. Studies of precursors such as NR or NMN should not automatically be attributed to directly administered NAD+.

07 / REFERENCES

Studies and sources

  1. Grant et al. · NAD+ metabolism following infusion (2019) ↗Original research · pilot study
Back to the atlasFurther information / Contact